ROBERT STERLING: Open Payments
NPI 1740723253 · PORT ALLEGANY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,743 in 86 payments from 16 companies in 2025. Trend: 2023 $1,804 · 2024 $2,038 · 2025 $1,743
Food & beverage: $1,589Education: $154
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 22 | $263 |
| ABBVIE INC. | 14 | $252 |
| Janssen Biotech, Inc. | 6 | $183 |
| Novartis Pharmaceuticals Corporation | 5 | $140 |
| Regeneron Healthcare Solutions, Inc. | 6 | $136 |
| PFIZER INC. | 6 | $121 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| UCB, Inc. | 4 | $79 |
| LEO Pharma Inc. | 3 | $76 |
| Lilly USA, LLC | 3 | $68 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, SKYRIZI, RINVOQ, CIBINQO, Bimzelx, ADBRY.
Industry payments across PA — which companies pay providers there.
